Express Pharma

Pelican BioThermal expands Asia operations

Launches a new network of distribution partners in the region

Pelican BioThermal, a global leader providing the largest range of innovative temperature-controlled packaging solutions serving the life sciences industry, has expanded its operations in Asia with the launch of a new network of distribution partners in the region.

Pelican BioThermal has joined forces with the region’s distinguished distributors, Pharmaserv Express of the Philippines and CMC Element of China, to further enhance its operations in Asia. Pharmaserv Express works closely with national health services to skillfully transport pharmaceutical products throughout the complex geography of the Philippines. CMC Element distributes a variety of healthcare products, including pharmaceuticals protected in temperature-controlled packaging, across the vast Chinese market using their extensive network.

The latest development demonstrates Pelican BioThermal’s continued growth in Asia and follows the company’s recent launch of its new operational facility in Singapore.

The new industry partnerships with these key distributors signals another major development in Pelican BioThermal’s expanding presence and support network in Asia, further enhancing the extending range of products and services offered by the company in the region. In particular, the new distributors enhance customer support for global customers shared with Pelican BioThermal, by offering local hours, local language and local service and inventory at the point of final distribution of pharma products.

The increasing network of distribution partners complements the company’s newly established Asia headquarters, which is co-located with Pelican BioThermal’s authorised distributor for Singapore, Enviropac.

The region continues to be an area of pronounced growth for Pelican BioThermal and forging links with these well – established distribution partners will increase the company’s global reach and support network for customers.

EP News Bureau

Comments are closed.